Lumen Bioscience News Today

Lumen Bioscience, a clinical-stage biopharma company developing biologic drugs for highly prevalent disease, has received $5.5 million in new funding from the U.S. Department of Defense, to develop technologies for needle-free vaccines.

Lumen Bioscience, a clinical-stage biopharma company developing biologic drugs for highly prevalent disease, has received $5.5 million in new funding from the U.S. Department of Defense, to develop technologies for needle-free vaccines.

Lumen Bioscience has been granted $16.2 million by the U.S. Department of Defense to advance its C. difficile infection (CDI) treatment.

Lumen Bioscience developed an enzyme that targets the methane-producing microorganisms in a cow’s digestive system. Cow burps are a major source of methane, a…

Lumen Bioscience was announced Friday as the winner of the $1.5 million Wilkes Center Climate Prize from the University of Utah to expand its work on reducing methane emissions in the atmosphere \u2014 by reducing cow farts.

Five finalists are waiting to find out who won a $1.5 million prize offered by the University of Utah, hoping to fund their innovative plans to help the planet \u2014 but only one can take home the money.

Defunct crypto exchange FTX and its sister firm Alameda want to retrieve more than $71 million from FTXs philanthropic arm and other life science...

FTX (CRYPTO: FTT) administrators are on a mission to reclaim over $71 million from the insolvent exchange's charitable and life science divisions.

Bankrupt cryptocurrency exchange FTX has filed suit against philanthropic organizations associated with it and six life sciences companies seeking the return of commingled customer funds.

/PRNewswire/ -- Global Plant-based Biologics Market Forecast Analysis: As per the report published by Research Dive, the global plant-based biologics market is...